An Investigational Immuno-therapy Study of Relatlimab Plus Nivolumab Compared to Various Standard-of-Care Therapies in Previously Treated Participants With Recurrent, Advanced or Metastatic Gastric Cancer or Gastroesophageal Junction Adenocarcinoma
Clinical trial NCT03704077 · WITHDRAWN
Trial details
- NCT number
- NCT03704077
- Sponsor
- Bristol-Myers Squibb
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-31
- Primary completion
- 2022-02-27
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.